Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV
Open Access
- 13 June 2022
- journal article
- research article
- Published by Elsevier in Cell Reports Methods
- Vol. 2 (6) , 100236
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute
- Hyundai Hope On Wheels
- CancerFree KIDS
- NCI (U54-CA232561)
- Kiadis Pharma (PCT-US2018/020187, PCT-US2019/032,670, PCT-US2020/018,384, PCT-US2020/025,454, PCT-US2020/02545, US62/805,394, US62/815,625, US62/900,245, US62/928,524, US62/987,935, US63/018,108, US63/105,722, WO2019/222,503-A1)
This publication has 45 references indexed in Scilit:
- Genome engineering using the CRISPR-Cas9 systemNature Protocols, 2013
- Normalization of mass cytometry data with bead standardsCytometry Part A, 2013
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Single‐cell mass cytometry adapted to measurements of the cell cycleCytometry Part A, 2012
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer CellsPLOS ONE, 2012
- In VitroandIn VivoAntitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL againstAcute Myeloid LeukemiaAdvances in Hematology, 2012
- Extracting a cellular hierarchy from high-dimensional cytometry data with SPADENature Biotechnology, 2011
- Expansion, Purification, and Functional Assessment of Human Peripheral Blood NK CellsJournal of Visualized Experiments, 2011
- Web‐Based Analysis and Publication of Flow Cytometry ExperimentsCurrent Protocols in Cytometry, 2010
- Self-complementary AAV Vectors; Advances and ApplicationsMolecular Therapy, 2008